File:Comirnaty2021En.png
Size of this preview: 800 × 383 pixels. Other resolutions: 320 × 153 pixels | 640 × 306 pixels | 1,024 × 490 pixels | 1,280 × 612 pixels | 2,560 × 1,225 pixels | 5,107 × 2,443 pixels.
Original file (5,107 × 2,443 pixels, file size: 529 KB, MIME type: image/png)
 | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
Summary
| Description |
English: Main results of the randomized controlled trial of Biontech-Pfizer's coronavirus vaccine (Tozinameran, Comirnaty, bnt162b2) versus placebo (0.9% saline injection) - 6-month follow-up. According to Thomas SJ, Moreira ED Jr, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021;385:1761-73. DOI: 10.1056/NEJMoa2110345
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2110345/suppl_file/nejmoa2110345_appendix.pdf |
| Date | |
| Source | Own work |
| Author | Nirts |
| Other versions |
[]
|
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
 
|
This file is made available under the Creative Commons CC0 1.0 Universal Public Domain Dedication. |
| The person who associated a work with this deed has dedicated the work to the public domain by waiving all of their rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law. You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.
|
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 17:16, 23 November 2024 | | 5,107 × 2,443 (529 KB) | Nirts | Typo correction |
| 10:42, 23 November 2024 |  | 4,896 × 2,376 (487 KB) | Nirts | Uploaded own work with UploadWizard |
File usage
The following page uses this file:
